Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 27, 2015 01:04 ET | Source: MorphoSys AG

MorphoSys AG Reports Results for the First Six Months of 2015

MUNICH, Germany, July 27, 2015 (GLOBE NEWSWIRE) -- Therapeutic Pipeline Exceeds 100 Drug Candidates in Research & Development Conference call (in English) today at 2:00pm CEST (1:00pm BST/8:00am...
July 23, 2015 01:37 ET | Source: MorphoSys AG

MorphoSys Announces Clinical Milestone in Blood Disorders Program

MARTINSRIED / MUNICH, Germany, July 23, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) announced today that it has received a milestone payment from...
July 20, 2015 08:07 ET | Source: MorphoSys AG

MorphoSys to Host Q2 2015 Conference Call on 27 July 2015

MARTINSRIED / MUNICH, Germany, July 20, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first six months' 2015 results on 27 July 2015 at 7:00 am...
June 01, 2015 11:05 ET | Source: MorphoSys AG

MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at ASCO Annual Meeting

MARTINSRIED / MUNICH, Germany, June 1, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today announced updated clinical data on its proprietary drug...
May 31, 2015 09:27 ET | Source: MorphoSys AG

MorphoSys Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASCO Meeting

Clinical Activity and Long-lasting Tumor Control Already Observed at Low Doses MOR202 is safe and tolerable in weekly and biweekly doses MOR202 showed early signs of clinical activity...
May 29, 2015 08:07 ET | Source: MorphoSys AG

MorphoSys to Present at Five Upcoming Conferences

MARTINSRIED / MUNICH, Germany, May 29, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following conferences: ASCO (American Society...
May 21, 2015 11:06 ET | Source: MorphoSys AG

MorphoSys to Present Data on Proprietary Programs at 20th Congress of the European Hematology Association

MARTINSRIED / MUNICH, Germany, May 21, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced the publication of three MorphoSys abstracts which were...
May 13, 2015 17:35 ET | Source: MorphoSys AG

MorphoSys to Present Data on Proprietary Programs at American Society of Clinical Oncology Annual Meeting

MARTINSRIED / MUNICH, Germany, May 13, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced the publication of three MorphoSys abstracts which were...
May 12, 2015 11:15 ET | Source: MorphoSys AG

MorphoSys to Present at Two Upcoming Investor Conferences

Martinsried / Munich, Germany, May 12, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following investor conferences in May: BofAML...
May 08, 2015 09:55 ET | Source: MorphoSys AG

Annual General Meeting of MorphoSys AG Elects New Supervisory Board Members

Martinsried / Munich, Germany, May 8, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its shareholders elected Ms. Wendy Johnson, Mr. Klaus...